MedTrace Logo

Breast Health in Chinese American Women

NCT01292200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 954

Last updated 2017-07-02

No results posted yet for this study

Summary

This four-and-a-half-year study will test the efficacy of viewing a theoretically based and culturally sensitive video followed by group discussion (vs. single viewing) in increasing mammography use. The results of this study will lead cancer control efforts to effectively decrease breast cancer screening disparities experienced by Chinese-America women.

Conditions

Interventions

BEHAVIORAL

watch DVD and small group discussion

Women in the small-group discussion mode will be called by their community educators to determine possible dates, times, and places for group meetings. The small group sessions will be conducted near the participants' homes. Each small-group will consist of 5-10 participants who will first view a 20-minute video together and then discuss the content of the video as well as their barriers to screening for about 30 minutes. A community educator and an RA at the study site will facilitate the discussion in Chinese languages according to a structured guide.

BEHAVIORAL

watch DVD

Women in the single video mode will receive a cultural video along with an information sheet on local free and low-cost screening programs by mail.

Sponsors & Collaborators

Principal Investigators

  • Judy (Huei-Yu) Wang, Ph.D. · Georgetown University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2016-12-21
Completion
2016-12-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01292200 on ClinicalTrials.gov